Immuneering (IMRX) Asset Utilization Ratio (2021 - 2023)

Immuneering's Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.0 for Q3 2023.

• On a quarterly basis, Asset Utilization Ratio fell 99.9% year-over-year to 0.0 in Q3 2023; TTM through Sep 2023 was 0.0, a 99.9% decrease from a year earlier, with the FY2022 full-year figure at 0.0, down 89.19% from the prior year.
• Asset Utilization Ratio fell to 0.0 in Q3 2023 per IMRX's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.02 in Q3 2021 and bottomed at 0.0 in Q3 2023.
• The 3-year median for Asset Utilization Ratio is 0.0 (2022), against an average of 0.01.
• Across the five-year window, Asset Utilization Ratio plunged 80.32% in 2022 and slumped 99.9% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then plunged by 80.32% to 0.0 in 2022, then plunged by 99.85% to 0.0 in 2023.
• Per Business Quant, the three latest IMRX Asset Utilization Ratio figures stand at 0.0 (Q3 2023), 0.0 (Q2 2023), and 0.0 (Q1 2023).